-
公开(公告)号:US06786064B2
公开(公告)日:2004-09-07
申请号:US09981237
申请日:2001-10-18
IPC分类号: C03B3700
CPC分类号: C03B32/00 , C03B11/005 , C03B11/08 , C03B2215/66 , C03C1/10 , C03C3/16 , C03C3/21 , C03C4/02
摘要: Provided are a process for the production of a precision press-molded article having a high transmittance and a method of treating a glass to color or decolor the glass, the process comprising heat-treating a press-molded article containing at least one selected from WO3, Nb2O5 or TiO2 in an oxidizing atmosphere to produce a glass molded article, and the method comprising heat-treating a colored glass containing at least one oxide of WO3 and Nb2O5 in an oxidizing atmosphere to decolor the glass, or heat-treating a glass containing at least one oxide selected from WO3, Nb2O5 or TiO2 in a non-oxidizing atmosphere to color the glass.
摘要翻译: 提供一种具有高透射率的精密压模制品的制造方法和玻璃的处理方法以使玻璃着色或脱色,该方法包括热处理含有选自WO 3中的至少一种的加压成型制品 ,Nb 2 O 5或TiO 2在氧化气氛中制造玻璃成形体,所述方法包括在氧化气氛中对含有至少一种WO 3和Nb 2 O 5的氧化物的着色玻璃进行热处理,以使所述玻璃脱色或热处理含有 在非氧化气氛中选自WO 3,Nb 2 O 5或TiO 2中的至少一种氧化物以使玻璃着色。
-
公开(公告)号:US06284758B1
公开(公告)日:2001-09-04
申请号:US09486327
申请日:2000-02-25
IPC分类号: A61K3150
CPC分类号: C07D401/12
摘要: An angiogenesis promoter and angiogenesis potentiator containing a pyridazinone compound of the formula (I) wherein each symbol is as defined in the specification, or a pharmacologically acceptable salt thereof, as an active ingredient. The pyridazinone compound (I) and a pharmacologically acceptable salt thereof in the present invention promote angiogenesis and potentiate the angiogenic effect of a drug having such effect, and are useful as an angiogenesis promoter and angiogenesis potentiator.
摘要翻译: 含有式(I)的哒嗪酮化合物的血管生成促进剂和血管生成增强剂,其中每个符号如说明书中所定义,或其药理学上可接受的盐作为活性成分。 本发明中的哒嗪酮化合物(I)及其药理学上可接受的盐促进血管生成并且增强具有这种作用的药物的血管生成作用,并且可用作血管生成促进剂和血管生成增强剂。
-
公开(公告)号:US5530001A
公开(公告)日:1996-06-25
申请号:US360705
申请日:1995-02-24
申请人: Masahide Nakajima , Norifumi Nakamura , Feng Wang , Koichi Yamanouchi , Kazutaka Hayashi , Hideaki Kido , Yoshiji Kubo , Minori Okita , Takeshi Uchida , Masahiro Watanabe , Katsumi Yamanaga , Hiroshi Shinyama , Toru Kawamura , Yuji Narita
发明人: Masahide Nakajima , Norifumi Nakamura , Feng Wang , Koichi Yamanouchi , Kazutaka Hayashi , Hideaki Kido , Yoshiji Kubo , Minori Okita , Takeshi Uchida , Masahiro Watanabe , Katsumi Yamanaga , Hiroshi Shinyama , Toru Kawamura , Yuji Narita
IPC分类号: A61K31/44 , A61K31/495
CPC分类号: A61K31/44 , A61K31/495 , Y10S514/824 , Y10S514/87 , Y10S514/925 , Y10S514/929
摘要: A novel pharmaceutical use of a dihydropyridine derivative of the formula (I) ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and each is an alkyl or the like; R.sub.4 is a hydrogen atom or the like; R.sub.5 is nitro, a halogenated alkyl, cyano or the like; X is a vinylene or an azomethine; A is an alkylene; and B is --N(R.sub.6) (R.sub.7) or a group of the formula ##STR2## wherein R.sub.6 and R.sub.7 are the same or different and each is an alkyl, an aralkyl, an aryl or the like; R.sub.8 and Ar are aryl or the like; and n is 0, 1 or 2, or an acid addition salt thereof for promoting PGI.sub.2 production, and for the treatment and prevention of hyperlipemia, arteriosclerosis and cerebral diseases.
摘要翻译: PCT No.PCT / JP94 / 00460 Sec。 371日期:1995年2月24日 102(e)日期1995年2月24日PCT 1994年3月22日PCT公布。 第WO94 / 23721号公报 日期:1994年10月27日。一种式(I)的二氢吡啶衍生物(Ⅰ)的新药用途,其中R 1,R 2和R 3相同或不同,各自为烷基等; R4是氢原子等; R5是硝基,卤代烷基,氰基等; X是亚乙烯基或偶氮甲碱; A是亚烷基; 并且B是-N(R6)(R7)或下式的基团:其中R6和R7相同或不同,并且各自是烷基,芳烷基,芳基等; R8和Ar是芳基等; 和n为0,1或2,或其酸加成盐,用于促进PGI2的产生,以及用于治疗和预防高脂血症,动脉硬化和脑疾病。
-
-